130 related articles for article (PubMed ID: 36413571)
1. Combination therapy with chitosan/siRNA nanoplexes targeting PDGF-D and PDGFR-β reveals anticancer effect in breast cancer.
Şalva E; Özbaş S; Alan S; Özkan N; Ekentok-Atıcı C; Kabasakal L; Akbuğa J
J Gene Med; 2023 Feb; 25(2):e3465. PubMed ID: 36413571
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of chitosan-mediated silencing of PDGF-B and PDGFR-β in the mesangial proliferative glomerulonephritis therapy.
Alan S; Şalva E; Yılmaz İ; Turan SÖ; Akbuğa J
Exp Mol Pathol; 2019 Oct; 110():104280. PubMed ID: 31265815
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Glomerular Mesangial Cell Proliferation by siPDGF-B- and siPDGFR-β-Containing Chitosan Nanoplexes.
Salva E; Turan SÖ; Akbuğa J
AAPS PharmSciTech; 2017 May; 18(4):1031-1042. PubMed ID: 27975193
[TBL] [Abstract][Full Text] [Related]
4. RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats.
Chen SW; Zhang XR; Wang CZ; Chen WZ; Xie WF; Chen YX
Liver Int; 2008 Dec; 28(10):1446-57. PubMed ID: 18466260
[TBL] [Abstract][Full Text] [Related]
5. Role of PDGF-D and PDGFR-β in neuroinflammation in experimental ICH mice model.
Yang P; Manaenko A; Xu F; Miao L; Wang G; Hu X; Guo ZN; Hu Q; Hartman RE; Pearce WJ; Obenaus A; Zhang JH; Chen G; Tang J
Exp Neurol; 2016 Sep; 283(Pt A):157-64. PubMed ID: 27302678
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the dual-faced effects of miR-141 with chitosan/miR-141 nanoplexes in breast cancer cells.
Kaban K; Salva E; Akbuga J
J Gene Med; 2019 Sep; 21(9):e3116. PubMed ID: 31389101
[TBL] [Abstract][Full Text] [Related]
7. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
Zhang H; Sun JD; Yan LJ; Zhao XP
Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
[TBL] [Abstract][Full Text] [Related]
8. The development of ternary nanoplexes for efficient small interfering RNA delivery.
Şalva E; Turan SÖ; Akbuğa J
Biol Pharm Bull; 2013; 36(12):1907-14. PubMed ID: 24432377
[TBL] [Abstract][Full Text] [Related]
9. Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.
Weigel MT; Ghazoui Z; Dunbier A; Pancholi S; Dowsett M; Martin LA
Breast Cancer Res; 2012 May; 14(3):R78. PubMed ID: 22608253
[TBL] [Abstract][Full Text] [Related]
10. In vitro silencing effect of chitosan nanoplexes containing siRNA expressing vector targeting VEGF in breast cancer cell lines.
Salva E; Akbuğa J
Pharmazie; 2010 Dec; 65(12):896-902. PubMed ID: 21284259
[TBL] [Abstract][Full Text] [Related]
11. A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.
Ustach CV; Huang W; Conley-LaComb MK; Lin CY; Che M; Abrams J; Kim HR
Cancer Res; 2010 Dec; 70(23):9631-40. PubMed ID: 21098708
[TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats.
Chen SW; Chen YX; Zhang XR; Qian H; Chen WZ; Xie WF
Gene Ther; 2008 Nov; 15(21):1424-35. PubMed ID: 18509379
[TBL] [Abstract][Full Text] [Related]
13. Effects of ribozyme targeting platelet-derived growth factor receptor beta subunit gene on the proliferation and apoptosis of hepatic stellate cells in vitro.
Chen YX; Lu CH; Xie WF; Zhang XR; Zhang ZB; Wei LX; Jin YX; Guo YJ
Chin Med J (Engl); 2005 Jun; 118(12):982-8. PubMed ID: 15978205
[TBL] [Abstract][Full Text] [Related]
14. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
[TBL] [Abstract][Full Text] [Related]
15. Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.
Najy AJ; Won JJ; Movilla LS; Kim HR
Mol Cancer Res; 2012 Aug; 10(8):1087-97. PubMed ID: 22689130
[TBL] [Abstract][Full Text] [Related]
16. RNA interference against platelet-derived growth factor receptor α mRNA inhibits fibroblast transdifferentiation in skin lesions of patients with systemic sclerosis.
Liu T; Zhang J; Zhang J; Mu X; Su H; Hu X; Liu W; Zhao E; Li W
PLoS One; 2013; 8(4):e60414. PubMed ID: 23577108
[TBL] [Abstract][Full Text] [Related]
17. miR-34c inhibits PDGF-BB-induced HAVSMCs phenotypic transformation and proliferation via PDGFR-β/SIRT1 pathway.
Wan WF; Zhang X; Huang CR; Chen LG; Yang XB; Bao KY; Peng TM
Mol Biol Rep; 2021 May; 48(5):4137-4151. PubMed ID: 34110576
[TBL] [Abstract][Full Text] [Related]
18. PDGF-D signaling in portal myofibroblasts and hepatic stellate cells proves identical to PDGF-B via both PDGF receptor type α and β.
Borkham-Kamphorst E; Meurer SK; Van de Leur E; Haas U; Tihaa L; Weiskirchen R
Cell Signal; 2015 Jul; 27(7):1305-14. PubMed ID: 25819339
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor receptor-beta, carrying the activating mutation D849N, accelerates the establishment of B16 melanoma.
Suzuki S; Heldin CH; Heuchel RL
BMC Cancer; 2007 Dec; 7():224. PubMed ID: 18076756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
